"Rags-To-Riches" Portfolio Outpacing S&P 500 By 2-To-1 Margin

The performance of the 14 largest cannabis, psychedelic and plant-based food stocks (those having market capitalizations of at least $400M, and trading for at least $1/share) in 2022 were just horrible, DOWN 70.5%. After such a massive decline, the market could well offer high returns for investors in 2023 and beyond and, to that end, I have created a basket of those 14 stocks - aptly named the Rags-to-Riches Portfolio - for 2023.

Below are how the various portfolio categories and constituents therein have performed year-to-date:

American Cannabis MSO constituents:
- Cresco (CRLBF): No change YTD,
- Curaleaf (CURLF): DOWN 6.1% YTD,
- Green Thumb (GTBIF): UP 1.1% YTD,
- TerrAscend (TRSSF): UP 54.5 % YTD,
- Trulieve (TCNNF): DOWN 18.0% YTD, and
- Verano (VRNOF): DOWN 3.2% YTD.
  - In total: UP 3.9% YTD
- For comparison purposes, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) is DOWN 5.2% YTD
Canadian Cannabis LP constituents:
- Canopy Growth (CGC): UP 2.6% YTD,
- Cronos (CRON): DOWN 16.7% YTD, and
- Tilray (TLRY): UP 5.7% YTD.
  - In total: DOWN 2.8% YTD
- For comparison purposes, the Global X Cannabis ETF (POTX) is DOWN 4.0% YTD
Psychedelic Drug Stock constituents:
- Atai (ATAI): DOWN 37.2% YTD,
- Compass Pathways (CMPS): UP 4.6% YTD, and
- GH Research (GHRS): UP 1.0% YTD.
  - In total: UP 3.5% YTD
- For comparison purposes, the AdvisorShares Psychedelics ETF (PSIL) is DOWN 5.0% YTD
Plant-Based Food Stock constituents:
- Beyond Meat (BYND): UP 53.6% YTD, and
- Oatly Group (OTLY): UP 22.4% YTD.
  - In total: UP 49.8% YTD
- No comparable plant-based food stock ETFs